| INTRODUCTION
Cancer is not a national or regional problem; it is a human problem, a global health problem. Consequently, it is appropriate for us to approach the study of cancer with a broadened global perspective. In doing so, we can use geographic variations in the incidence and histopathology of certain cancers to gain a better understanding of the pathophysiology, tumor biology, and risk factors that contribute to oncogenesis.
Esophageal carcinoma (EC) is an excellent example of where such a global approach can yield useful information. EC is the eighth most common cancer worldwide and the sixth leading cause of cancer related mortality. 1 Unfortunately, it is often associated with a poor prognosis having a 5-year survival ranging from 4 to 40% depending on stage, and an 18% overall 5-year survival. 2 It has been well described that the incidence of EC varies greatly throughout the world, ranging from the second most common cancer in some countries to one of the least common cancers in other countries. 3 More importantly, it has become clear that there are geographic variations in the histological subtypes of EC with esophageal adenocarcinoma (AC) being more prevalent in many of the more developed countries while esophageal squamous cell cancer (SCC) predominates in eastern Asia and Africa. 4, 5 In this study, we have analyzed several global and regional databases to provide a comprehensive analysis of the global impact of EC.
Specifically, we focus on analyzing differences in incidence and mortality by geographic location, socio-economic development, and race. Furthermore, we were able to analyze geographic variations in EC by histological subtypes to identify regions where one subtype predominates. Finally, we analyzed future trends in EC incidence and mortality based on geographic regions and economic development.
Authors analyzed global trends in esophageal cancer incidence and mortality.
There is a focus on differences by geographic location, human development index, and histopathology.
2 | METHODS
| GLOBOCAN 2012
We utilized the publically accessible GLOBOCAN database 6 for 2012
to determine incidence and mortality for esophageal cancer. The data was analyzed using intrinsic variables within the GLOBOCAN database including varying geographic parameters and the Human Development Index (HDI; discussed below). We used absolute incidence in addition to the age-standardized rate (ASR) to compensate for the varying aging demographics within different geographic regions. We also used GLOBOCAN to estimate future incidence and mortality with demographic changes. Details regarding the GLOBOCAN data sources and methods are as detailed previously. Population. The World Standard Population was used previously described, 8, 9 and is expressed per 100 000. The ASR can be applied to both incidence (ASR-I) and mortality (ASR-M).
| Human development index
The Human Development Index (HDI) is a calculated by the United Nations Development Program (UNDP) as an estimate of social and economic development. It takes into account three fundamental areas of human development: (i) life expectancy at birth; (ii) adult literacy rate and primary-to tertiary-education enrollment rates; and (iii)
Gross domestic product per-head adjusted for purchasing-power parity (US$). 10 Based on the HDI score, countries are stratified into four pre-defined categories of low (LHDI < 0.55), medium (0.55 ≤ MHDI < 0.70), high (0.70 ≤ HHDI < 0.80), and very high (0.80 ≤ VHHDI < 1.00).
3 | RESULTS
| Geographic variations in incidence of esophageal carcinoma
Using the 2012 data from GLOBOCAN we began by analyzing the age standardized incidence rate (ASR-I) of EC based on geography. Using a global heat map, we observed an increased incidence of EC in East Asia and Eastern Africa (Fig. 1 ). While the high incidence of EC in Asia has been known and documented for some time, the similarly high incidence in Eastern Africa has only recently been discussed and further research is required to better understand the etiology of this geographic variability.
4,11
When we analyzed the data by continents (Fig. 2 ), the scale of Asia's contribution to the global prevalence of EC became apparent.
The Asian subcontinent leads the world in the actual number of EC as well as the ASR-I. With the highest ASR-I of any continent (7.7 per 100 000), and the densest population in the world, Asia represents 75% of the world's burden of EC. Interestingly, while Europe has the second highest incidence of EC by volume, Africa has a much higher ASR of 4.5.
In order to better understand which regions within the continents were specifically contributing to the observed incidence reported above ( Fig. 2) , we analyzed smaller geographic regions within the continents for their respective incidence (Table 1) . Not surprisingly,
Eastern Asia appeared at the top of the list with an ASR-I of 11.
Consistent with our earlier observation, Eastern and Southern Africa had the second highest ASR-I of 9.7. Interestingly, within the same continent, Western Africa had the lowest incidence rate of EC in the world. While this dichotomy is certainly multifactorial, it underscores the importance of geography and environment-potentially over race and genetics. However, there is at least one genetic component that has a clear and undeniable impact on EC incidence-that of gender.
While the male predominance in EC is again well established in the literature, 4, 12 what we are able to appreciate from these data is that even regions with relatively low incidences of EC maintain a male predominance. The male: female incidence ratio within the subregions ranges from 1.4 to 15 with an average threefold increase in males versus females worldwide. | 569
Finally, we analyzed the top 10 countries with the highest incidence of EC. Not surprisingly, China had the highest incidence by volume over any other country (Fig. 3) . While we previously showed Asia represented 75% of the world incidence, China alone accounts for 50% of the world's EC incidence. However, the age standardized incidence rate of China is lower than that of several other countriesmany of which are located in Eastern/Southern Africa.
| Geographic variations in mortality of esophageal carcinoma
As expected, the geographic variations in EC mortality closely mirror the incidence rates. Due to the poor prognosis associated with EC, 2 regions of high incidence show a matched increase in mortality. Figure 4 represents a heat map of the world mortality rate. Similar to the heat map of EC incidence, (Fig. 1) we are able to appreciate higher mortality rates within the Eastern Asian and Eastern African regions.
When we analyzed mortality by continents, Asia was again found to have the highest mortality in both volume and age standardized mortality rates (ASR-M) (Fig. 5) . Asia accounts for 75% of the world EC mortality burden with an ASR-M of 6.7. Europe was again second highest in mortality volume, but actually lowest in ASR-M. When breaking down the continents into regional geographic areas (Table 2) , we find that Eastern Asia has the highest mortality volume and rate, followed closely by Eastern and Southern Africa for ASR-M.
Interestingly, the male: female mortality ratios also remain very closely matched to the incidence ratios. They range from 1.4 to 16, with the world average again showing a threefold increased mortality rate in men versus women. Finally, we identified the top 10 countries with the highest age adjusted mortality (Fig. 6) . Interestingly, the rank order list is identical to that of the 10 countries with the highest ASR-I's highlighting the lethality of EC.
| Variations in EC incidence and mortality by human development index
The Human Development Index (HDI) is often used to organize countries based on their level of socio-economic development. 10 The Here we sought to analyze the incidence and mortality variations based on HDI (Figs. 7 and 8) . Interestingly, the MHD had the highest incidence and mortality of all the four HDI categories; this was true by volume and ASR. The second highest category for incidence and mortality turned out to be the VHHD subgroup. However, this is true only in volume; if analyzed based on ASR, the LHD subgroup has the second highest incidence and mortality. Finally, the subgroup with the lowest incidence and mortality is the HHD group.
| Global variations in esophageal adenocarcinoma and squamous cell carcinoma
The two main histological subtypes of EC are adenocarcinoma (AC) and squamous cell carcinoma (SCC). While SCC has long been, and still is the most common form of EC, there has been a steady increase in the incidence of AC-particularly in western developed countries. We sought to analyze the geographical variations in the incidence of esophageal AC and SCC. Using the CI5X database, we found that there seemed to be a reciprocal relationship between SCC and AC (Fig. 9) .
Regions with high incidence of SCC, such as Asia, Africa, and South America had low rates of AC. Conversely, Oceana and North America had higher rates of AC and low rates of SCC.
We found that the predominance of EC for the male gender persisted even among the varying histological subtypes. The average male: female ratio for SCC is 2.5, and for AC the ratio is 4.4 (Fig. 9) . The most dramatic difference between male and female EC incidence was seen in North America where male AC has a sevenfold higher incidence compared with female AC.
After identifying the regions with the highest rates of SCC (Asia) and AC (North America), we looked within the continents to identify any regions with significant contributions. Within Asia, we found that China had a substantially higher incidence rate of SCC relative to the remaining countries (Fig. 10) . The ASR-I for China (38.8) was more than double that of the second highest country, Iran (15.2). For AC, we were able to subcategorize North America into Canada and 42 states for which we had data available (Fig. 11) . Notably, there were two states within the region, Mississippi and South Carolina, where the incidence rates for SCC is slightly greater than that of AC. For the remainder of the states and Canada, AC had varying degrees of increased incidence over SCC. to Caucasians (Fig. 12) . The incidence rate of SCC is 4.8-fold higher in
African American males compared with Caucasians. Conversely, the incidence rates for AC were fivefold higher in Caucasian males compared to African Americans.
| Predictions in esophageal carcinoma incidence and mortality
While the incidence of esophageal AC continues to rise in certain geographic locations, the rates of SCC often decrease proportionally. 13 Overall, the incidence rates of EC (AC + SCC) have been steady or even declining. 14, 15 However, there will still be increases in the incidence and global burden of EC due to demographic shifts in age. In order to evaluate this, we analyzed the predicted incidence and mortality for EC ranging from 2012 to 2035. When looking at all ages, we see a significant increase in the global EC burden from 455, in 2012 to 808508 in 2035 (Fig. 13) . Not surprisingly, the majority of the EC incidence originates from Asia, which is estimated to contribute over 80% of the world's EC burden in 2035. While
Asia certainly represents the highest number of EC over the time period, the greatest percent increase in incidence is seen in Africa, with a predicted increase in EC incidence of 104% over the time period studied.
Interestingly, Europe has the second highest incidence of EC by volume, but the rate of rise is significantly lower than that of the other continents with a percent increase of only 27%.
When analyzing the predicted mortality rates of EC by continents, we find the trends closely mirror those of EC incidence. Asia continues to be the main contributor to EC mortality with death rates expected to approach 590 696 in 2035, representing over 80% of the world's EC mortality (Fig. 14) . This is nearly a twofold increase in mortality for Asia from 2012 to 2035. Africa again has the highest percent increase of all continents with a 105% increase over the studied timeframe. Interestingly, Africa is projected to surpass the mortality rates of Europe by 2035. This is partially due to the very low rate of increase in European EC mortality, which has a percent increase of only 29% from 2012 to 2035.
| DISCUSSION
In this study, we sought to provide a global overview of EC incidence and mortality based on geographic variations. There are several striking results from this analysis, one of which is the remarkably high contribution of Asia to the world's total EC incidence and mortality.
This would not be unexpected if we were looking only at the incidence volume alone as Asia makes up 60% of the world population. 16 However, when looking at incidence and mortality rates, we still find Asia leads the world with the highest ASR-I and ASR-M (Figs. 2 and 5 ). This is largely due to China, which accounts for approximately 50% of the world's EC incidence and is consistent with reports of increasing EC burden within China 17 where it is the third most common cancer in men. 18 This is in contrast with western countries like the USA where EC is not even among the top 10.
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The high incidence of EC in Asia has been observed for several decades now, and histological analysis has shown that the primary subtype of EC in Asia is SCC. 5, 11, 19, 20 This is consistent with our findings, which show that SCC has a 19-fold higher incidence in Asian males compared with AC (Fig. 9) . While the bias toward SCC is prevalent throughout Asia, China is the principal constituent responsible for the high rates of SCC with a 77-fold higher incidence of SCC in Chinese males compared to AC (Fig. 10) . Consequently, there has been a fair amount of epidemiological research into understanding why rates of SCC are so high in Eastern Asia with much of the effort focused on identification of risk factors. 4, 11 Certainly, there are several well-defined risk factors that predispose one to SCC of the esophagus, chief among them are smoking and alcohol use.
China is the world leader in tobacco use and accounts for more cigarette consumption than all other low-and middle-income countries combined. 21 Unfortunately, the high intensity of smoking (cigarettes per day) combined with the high prevalence, and multiplied by the enormous population density results in an increasing tobacco consumption rate in China. There has been significant data to correlate tobacco use to SCC of the esophagus with some studies finding a 2-6 fold increased risk of EC with smoking (depending on pack year history and current smoking status) as an independent risk factor. [22] [23] [24] However, these studies and others have shown that tobacco use in conjunction with alcohol consumption function synergistically to result in significantly higher risks for SCC. [22] [23] [24] [25] [26] Castellsagué et al found that either moderate cigarette smoking or moderate alcohol use alone had minimal effects on EC risk. However, in combination, tobacco, and alcohol use FIGURE 11 ASR-I of both esophageal AC and SCC for United States where data was available. Canada included as reference resulted in a 12-fold increased incidence in men and a 19-fold increase in women. 24 While this study was conducted in an area with high endemic rates of SCC, similar results have been seen in studies conducted in the United States where the incidence of SCC is low (Fig. 11) . Brown et al showed that the combination of smoking and alcohol consumption may account for more than 90% of esophageal SCC. 26 Similar to tobacco use, alcohol consumption alone is only a moderate independent risk factor for EC. However, it warrants investigation and several studies have now looked into the biochemical mechanism of how alcohol use confers a higher risk of EC with a particular focus on alcohol metabolism. [27] [28] [29] The first step in alcohol metabolism is the conversion of ethanol to acetaldehyde. Acetaldehyde is subsequently metabolized to acetate by aldehyde dehydrogenase (ALDH). Deficiency of ALDH results in accumulation of acetaldehyde, which manifests with symptoms of facial flushing, nausea, and headaches after only a small quantity of alcohol ingestion.
ALDH deficiency (via a dominant negative allele) has been documented to be essentially absent in all parts of the world except East Asia 30 where it is present in 36% of the East Asian population. 31 It is well established that acetaldehyde acts as a carcinogen, 32 and its accumulation within the East Asian population has been identified as a contributor to the pathogenesis of EC. [27] [28] [29] Unfortunately, similar to tobacco use, China has an increasing alcohol consumption 33 that will certainly contribute to the increasing incidence of EC in Asia as seen in our predictions (Figs. 13 and 14 ).
Strikingly, Africa shows the highest percent increase in EC incidence and mortality over the next several decades ( Fig. 13 and 14) . This is likely due to the high ASR-I and ASR-M coupled with the expanding population. Indeed, Africa has the highest rate of population growth among major areas and is expected to account for more than half of the global population increase between now and 2050. 34 In contrast, Europe is expected to experience a shrinking population over the next several decades. 34 Not surprisingly, our predictions in EC incidence and mortality reflect these projections and
show Africa eventually surpassing Europe in both incidence and mortality ( Figs. 13 and 14) .
While the majority of focus on EC has been on Asia and China, Africa has a very unique composition of EC incidence and mortality. | 575 prevalence of tobacco smoking of all continents. 35 However, one study found that several nations of East/Central Africa and
Madagascar had the highest cigarette use among men while the lowest use was in nations of West/Central Africa. 36 In addition, there has been some research to suggest that the high incidence of EC within specific regions of Africa may be due in part to consumption of Fusarium contaminated food or nutritional deficiencies. [37] [38] [39] With all the emphasis on environmental and external factors that predispose a population to developing a specific type of EC, there has been little discussion on any intrinsic or genetic factors that may also contribute. When analyzing our data on variations between esophageal AC versus SCC, we made an interesting observation. Even in a country that has a bias toward AC, such as the United States, African Americans (AA) and Asians still show higher rates of SCC when compared to the rest of the country (Fig. 12 ). This suggests that either these populations (AA and Asian) recreate lifestyle choices and environments similar to their original countries, or that there may be certain intrinsic or genetic components that predispose toward developing SCC over AC. Brown et al looked into the higher rates of SCC in AAs and concluded that nearly all cases of esophageal SCC in AA's was explained by the combination of four risk factors: tobacco use, alcohol use, low income, and lack of raw fruits and vegetables. 26 Interestingly however, the incidence rate for SCC in the non-exposed AA population, albeit low (0.23), was approximately four times higher than the non-exposed Caucasian population. In order to identify any underlying genetic components, recent genomewide association studies and whole genome sequencing studies have been undertaken. While a number of susceptibility loci and high frequency gene mutations have been identified, further investigation is needed to understand the complex gene-environmental interactions involved. [40] [41] [42] [43] [44] [45] [46] There is, however, a genetic component with an extremely high penetrance despite geographical or histological variations. The male gender carries a significantly increased risk for developing EC. While the gender difference is most dramatic in esophageal AC, there is a consistent gender bias toward males for esophageal SCC as well. is certainly an increased prevalence of tobacco use, alcohol consumption, and Barrett's esophagus in men [47] [48] [49] ; the strong male predominance cannot be fully explained by gender related differences in known risk factors alone. 50 Some research suggests that sex hormones may play a protective role in the development of EC. One study found that hormone replacement therapy in women resulted in a 50% reduced risk of cancer. 51 This is supported by data showing a reduced risk of EC in breast-feeding women.
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In summary, the results of our study highlight the global cancer burden of EC, which is expected to increase significantly in the coming decades irrespective of geography. Asia, and China in particular, will continue to be the areas most burdened by EC. Africa, with its projected increase in population density is expected to surpass the incidence and mortality rates of Europe. Finally, the male predominance of EC was observed throughout our analysis despite geography or histological subtypes. Further investigations are required to better understand the differences between eastern and western Africa's EC incidence as well as the male to female dichotomy.
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